Fluoroscopic left ventricular lead position and the long-term clinical outcome of cardiac resynchronization therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 7, 2011, Pages 785-797

  Foley, Paul W X ^a   Chalil, Shajil ^a   Ratib, Karim ^a   Smith, Russell ^a   Prinzen, Frits ^b   Auricchio, Angelo ^c   Leyva, Francisco ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c DIVISION OF CARDIOLOGY   (Switzerland)

Author keywords

Cardiac resynchronization therapy; Lead position; Mortality

Indexed keywords

ADVERSE OUTCOME; AGED; ARTIFICIAL HEART PACEMAKER; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CLINICAL TRIAL; DEFIBRILLATOR; DIABETES MELLITUS; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; QRS COMPLEX; REVIEW; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; FEMALE; FLUOROSCOPY; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME;

EID: 84860410364     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03114.x     Document Type: Review

References (26)

1. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. For the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 2005;352:1539-1549. (Pubitemid 40517094)
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass D, De Marco T, Carson P, et al. For the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Eng J Med 2004;350:2140-2150.
3. Cazeau S, Leclercq C, Lavergene T, Walker S, Varma C, Linde C, Garrigue S, et al. Effects of multisite biventricular pacing in patients with heart failure and interventricular conduction delay. N Engl J Med 2001;344:873-880. (Pubitemid 32224395)
4. Abraham WT, Fisher WG, Smith AL, Deluergio DB, Leon AR, Kocovic DZ, Packer M, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853. (Pubitemid 34603028)
5. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P, Van der Wall EE, et al. Effectiveness of resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 2002;92:1238-1240.
6. Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y, Huvelle E, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104:3026-3029. (Pubitemid 34014051)
7. Gold MR, Auricchio A, Hummel JD, Giudici MC, Ding J, Tockman B, Spinelli J. Comparison of stimulation sites within left ventricular veins on the acute hemodynamic effects of cardiac resynchronization therapy. Heart Rhythm 2005;2:376-381. (Pubitemid 40439283)
8. Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, Guarnieri T, et al. Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol 2009;20:764-768.
9. Gasparini M, Mantica M, Galimberti P, Bocciolone M, Genovese L, Mangiavacchi M, Marchesina UL, et al. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy? Pacing Clin Electrophysiol 2003;26:162-168. (Pubitemid 36399132)
10. Rossillo A, Verma A, Saad EB, Corrado A, Gasparini G, Marrouche NF, Golshayan AR, et al. Impact of coronary sinus lead position on biventricular pacing: Mortality and echocardiographic evaluation during long-term follow-up. J Cardiovasc Electrophysiol 2004;15:1120-1125. (Pubitemid 39426037)
11. Kronborg MB, Albertsen AE, Nielsen JC, Mortensen PT. Longterm clinical outcome and left ventricular lead position in cardiac resynchronization therapy. Europace 2009;11:1177-1182.
12. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-969.
13. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-1985. (Pubitemid 44738448)
14. Barnett D, Phillips S, Longson C. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance. Heart 2007;93:1134-1135. (Pubitemid 47310998)
15. Guyatt GH, Sullivan MJ, Thompson PJ. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
16. Albertsen AE, Nielsen JC, Pedersen AK, Hansen PS, Jensen HK, Mortensen PT. Left ventricular lead performance in cardiac resynchronization therapy: Impact of lead localization and complications. Pacing Clin Electrophysiol 2005;28:483-488. (Pubitemid 40847496)
17. Ritter P, Padeletti L, Gillio-Meina L, Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing: Comparison between echo and peak endocardial acceleration measurements. Europace 1999;1:126-130.
18. Lakatos E. Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics 1988;44:229-241. (Pubitemid 18098824)
19. Helm RH, Byrne M, Helm PA, Daya SK, Osman NF, Tunin R, Halperin HR, et al. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation 2007;115:953-961. (Pubitemid 46328288)
20. Rademakers L, van Kerckhoven R, van Deursen C, Strik M, van Hunnik A, Kuiper M, Lampert A, et al. Myocardial infarction does not preclude electrical and hemodynamic improvement on CRT in dyssynchronous canine hearts. Circulation Arrhyth Electrophysiol 2010;3:361-368.
21. Michael B, Rainer H, Fabian S, Anne H, Harald Kh, Patrick S, Malte K, et al. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization. Am J Cardiol 2007;100:1671-1676.
22. Becker M, Franke A, Breithardt OA, Ocklenburg C, Kaminski T, Kramann R, Knackstedt C, et al. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: A two-dimensional strain echocardiography study. Heart 2007;93:1197-1203. (Pubitemid 47492902)
23. Chalil S, Foley P, Muyhaldeen S, Patel K, Yousef Z, Smith R, Frenneaux M, et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace 2007;9:1031-1037. (Pubitemid 351773274)
24. Chalil S, Stegemann B, Muhyaldeen S, Khadjooi S, Foley P, Smith R, Leyva F. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;10:1201-1207.
25. Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007;153:105-112. (Pubitemid 44880886)
26. Dekker AL, Phelps B, Dijkman B, Van der Nagel T, Van der Veen FH, Geskes GG, Maessen JG. Epicardial left ventricular lead placement for cardiac resynchronization therapy: Optimal pace site selection with pressure-volume loops. J Thorac Cardiovasc Surg 2004;127;1641-1647. (Pubitemid 38725442)